Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy

NCT01000246 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT01000246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01000246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy
Lead sponsor
St. Antonius Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2009
Enrollment
50 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, mamma carcinoma